Etazolate

This classification denotes an anxiolytic with the molecular formula C14H19N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I89Y79062L, chemically known as 1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid, 1-ethyl-4-((1-methylethylidene)hydrazino)-, ethyl ester but generally known as etazolate, which bears US NIH Compound Identifier 3277. European Medicines Agency schedules Etazolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07267MIG. The term ETAZOLATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). ETAZOLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etazolate under HS 29339990 and SITC 51577. As of Q4 2014, ETAZOLATE remains the US FDA Preferred Term for this commodity. Etazolate bears US NLM identifiers UMLS ID C0014958 and NCI Concept Code C73334. SMILES: O(C(=O)C1C(N/N=C(/C)C)C2C(N(NC2)CC)NC1)CC.